RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+27.41%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$2.58B
AUM Growth
+$2.58B
(-1.6%)
Cap. Flow
-$171M
Cap. Flow
% of AUM
-6.65%
Top 10 Holdings %
Top 10 Hldgs %
47.96%
Holding
78
New
7
Increased
10
Reduced
27
Closed
8
Top Buys
| 1 |
Ventyx Biosciences
VTYX
|
$47.7M |
| 2 |
Penumbra
PEN
|
$33.9M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$33.7M |
| 4 |
Stryker
SYK
|
$31.9M |
| 5 |
Pliant Therapeutics
PLRX
|
$30.1M |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$151M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$72.8M |
| 3 |
argenx
ARGX
|
$37.3M |
| 4 |
The Beauty Health Co
SKIN
|
$36.3M |
| 5 |
Centene
CNC
|
$28.7M |
Sector Composition
| 1 | Healthcare | 98.01% |
| 2 | Consumer Staples | 0.96% |
| 3 | Industrials | 0.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Elevance Health
ELV
$72.4B
| $32M | 1.24% |
70,487
-13,500
| -16% | -$6.13M |
|
|
SNCE
27
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
| $31.9M | 1.24% |
19,808,234
| – | – |
|
28
Prothena Corp
PRTA
$452M
| $31.9M | 1.24% |
525,575
-210,600
| -29% | -$12.8M |
|
|
29
Stryker
SYK
$149B
| $31.9M | 1.24% |
+157,321
| New | +$31.9M |
|
30
Entrada Therapeutics
TRDA
$202M
| $30.8M | 1.19% |
1,954,419
| – | – |
|
|
MDVL
31
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
| $26.9M | 1.04% |
34,604,516
+9,411,765
| +37% | +$7.3M |
|
|
OSH
32
DELISTED
Oak Street Health, Inc.
OSH
| $26M | 1.01% |
1,061,295
-322,324
| -23% | -$7.9M |
|
33
Absci
ABSI
$356M
| $25.1M | 0.98% |
8,031,094
| – | – |
|
|
34
The Beauty Health Co
SKIN
$254M
| $24.9M | 0.96% |
2,109,564
-3,076,784
| -59% | -$36.3M |
|
35
Atara Biotherapeutics
ATRA
$88.7M
| $23.6M | 0.92% |
6,242,756
| – | – |
|
|
36
Centene
CNC
$14.8B
| $22M | 0.85% |
282,460
-368,987
| -57% | -$28.7M |
|
37
Scholar Rock
SRRK
$3.3B
| $21.8M | 0.84% |
3,140,026
-263,900
| -8% | -$1.83M |
|
38
Annexon
ANNX
$225M
| $21.7M | 0.84% |
3,503,190
| – | – |
|
|
AUGX
39
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $20.9M | 0.81% |
14,380,327
| – | – |
|
40
RAPT Therapeutics
RAPT
$187M
| $18.9M | 0.73% |
784,832
-33,000
| -4% | -$794K |
|
41
Ionis Pharmaceuticals
IONS
$9.64B
| $18M | 0.7% |
+407,659
| New | +$18M |
|
|
GRTS
42
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $17.9M | 0.69% |
6,952,760
| – | – |
|
43
Stevanato
STVN
$6.36B
| $16M | 0.62% |
946,825
-169,000
| -15% | -$2.86M |
|
|
ALLK
44
DELISTED
Allakos
ALLK
| $15.6M | 0.6% |
2,545,275
| – | – |
|
45
Shattuck Labs
STTK
$61.3M
| $15.2M | 0.59% |
5,619,914
| – | – |
|
|
KLRS
46
Kalaris Therapeutics, Inc. Common Stock
KLRS
$85.5M
| $15.1M | 0.58% |
1,907,969
+1,084,598
| +132% | +$8.56M |
|
47
LAVA Therapeutics
LVTX
$41.3M
| $12.9M | 0.5% |
2,816,196
| – | – |
|
48
Revolution Medicines
RVMD
$7.43B
| $12.3M | 0.48% |
+625,000
| New | +$12.3M |
|
49
Jazz Pharmaceuticals
JAZZ
$7.99B
| $10.9M | 0.42% |
81,464
-11,800
| -13% | -$1.57M |
|
50
Stoke Therapeutics
STOK
$1.08B
| $10.7M | 0.42% |
835,830
-1,157,438
| -58% | -$14.9M |
|